US4929605A
(en)
*
|
1987-10-07 |
1990-05-29 |
Merrell Dow Pharmaceuticals Inc. |
Pharmaceutical composition for piperidinoalkanol derivatives
|
CN1053570C
(zh)
|
1987-10-07 |
2000-06-21 |
默尔多药物公司 |
哌啶子基链烷醇的药用组合物-减充血剂复方的制备方法
|
AR240018A1
(es)
*
|
1987-10-07 |
1990-01-31 |
Merrell Pharma Inc |
Procedimiento para preparar una composicion que comprende derivados de piperidinoalcanol.
|
US4908372A
(en)
*
|
1988-10-13 |
1990-03-13 |
Merrell Dow Pharmaceuticals Inc. |
Antihistaminic piperidinyl benzimidazoles
|
ZA90341B
(en)
*
|
1989-01-23 |
1990-10-31 |
Merrell Dow Pharma |
Liquid pharmaceutical composition for piperidinoalkanol derivatives
|
DE3917241A1
(de)
*
|
1989-05-26 |
1990-11-29 |
Schaper & Bruemmer Gmbh |
4-(hydroxydiphenylmethyl)-1-piperidyl-phenylalkan-derivate
|
US5182097A
(en)
*
|
1991-02-14 |
1993-01-26 |
Virginia Commonwealth University |
Formulations for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
|
US5190029A
(en)
*
|
1991-02-14 |
1993-03-02 |
Virginia Commonwealth University |
Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
|
TW198008B
(fr)
*
|
1991-04-08 |
1993-01-11 |
Green Cross Corp |
|
HU211019B
(en)
*
|
1991-12-02 |
1995-09-28 |
Richter Gedeon Vegyeszet |
Process for producing new 1,2,3,6-tetrahydropyridine and piperidine derivatives substituted with n-(hydroxylalkyl) group and compositions comprising such compounds
|
AU669156B2
(en)
*
|
1992-02-13 |
1996-05-30 |
Merrell Dow Pharmaceuticals Inc. |
Piperidinyl thiacyclic derivatives
|
US5631375A
(en)
*
|
1992-04-10 |
1997-05-20 |
Merrell Pharmaceuticals, Inc. |
Process for piperidine derivatives
|
WO1993021156A1
(fr)
*
|
1992-04-10 |
1993-10-28 |
Merrell Dow Pharmaceuticals Inc. |
Derives de piperidine 4-diphenymethylique et leur procede de preparation
|
JPH07506828A
(ja)
|
1992-05-11 |
1995-07-27 |
メレルダウファーマス−ティカルズ インコーポレイテッド |
肝臓が損われた患者での抗ヒスタミン剤としてのターフェナジン誘導体の用途
|
JP3041954B2
(ja)
*
|
1992-08-03 |
2000-05-15 |
セプラコア インコーポレーテッド |
アレルギー疾患治療用のテルフェナジン代謝物及びその光学的に純粋な異性体
|
US5654433A
(en)
*
|
1993-01-26 |
1997-08-05 |
Merrell Pharmaceuticals Inc. |
Process for piperidine derivatives
|
US20020007068A1
(en)
*
|
1999-07-16 |
2002-01-17 |
D'ambra Thomas E. |
Piperidine derivatives and process for their production
|
AU670004B2
(en)
|
1993-06-24 |
1996-06-27 |
Albany Molecular Research, Inc. |
Piperidine derivatives and process for their production
|
US6147216A
(en)
*
|
1993-06-25 |
2000-11-14 |
Merrell Pharmaceuticals Inc. |
Intermediates useful for the preparation of antihistaminic piperidine derivatives
|
CA2362339C
(fr)
*
|
1993-06-25 |
2005-08-02 |
Merrell Pharmaceuticals Inc. |
Nouveaux intermediaires pour la preparation de derives de 4-diphenylmethyl/diphenylmethoxy piperidine, antihistaminiques
|
WO1995010278A1
(fr)
*
|
1993-10-15 |
1995-04-20 |
Hoechst Marion Roussel, Inc. |
Traitement des troubles allergiques par le carboxylate de terfenadine
|
CA2173467A1
(fr)
*
|
1993-10-25 |
1995-05-04 |
Keith D. Ertel |
Composition pharmaceutique stable a base de terfenadine et d'ibuprofene
|
MX9605611A
(es)
*
|
1994-05-16 |
1998-05-31 |
Merrell Pharma Inc |
Procedimiento y sales diastereomericas utiles para la resolucion optica de a-(4-(1,1-dimetiletil)fenil)-4-(hidroxidifenil-metil)-1-pipe ridinbutanol racemico y compuestos derivados.
|
US20030045722A1
(en)
*
|
1994-05-18 |
2003-03-06 |
Henton Daniel R. |
Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
|
DK0766668T3
(da)
*
|
1994-05-18 |
2002-10-28 |
Aventis Pharma Inc |
Fremgangsmåde til fremstilling af vandfrie og hydratformer af som antihistaminer anvendelige piperidinderivater, polymorfer og pseudo-morfer deraf
|
CN101497581B
(zh)
*
|
1994-05-18 |
2012-07-11 |
安万特萨博Ⅱ有限公司 |
抗组胺哌啶衍生物,其多晶形物和假同晶物的无水和水合物形式的制备方法
|
CA2198084C
(fr)
|
1994-08-25 |
2000-03-28 |
Timothy P. Burkholder |
Nouveaux derives de substitution de piperidines pour le traitement des allergies
|
AU701042B2
(en)
*
|
1995-02-28 |
1999-01-21 |
Aventisub Llc |
Pharmaceutical composition for piperidinoalkanol compounds
|
AU705427B2
(en)
*
|
1995-05-08 |
1999-05-20 |
Aventisub Ii Inc. |
Alpha-(substituted alkylphenyl) -4-(hydroxydiphenylmethyl)-1-piperidine butanol derivatives, their preparation and their use as anti-histamines, anti-allergy agents and bronchodilators
|
US5574045A
(en)
*
|
1995-06-06 |
1996-11-12 |
Hoechst Marion Roussel, Inc. |
Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
|
US5906747A
(en)
*
|
1995-11-13 |
1999-05-25 |
Biosepra Inc. |
Separation of molecules from dilute solutions using composite chromatography media having high dynamic sorptive capacity at high flow rates
|
US6211199B1
(en)
|
1995-11-17 |
2001-04-03 |
Aventis Pharmaceuticals Inc. |
Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseases
|
US6423704B2
(en)
|
1995-12-20 |
2002-07-23 |
Aventis Pharmaceuticals Inc. |
Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseases
|
US6194406B1
(en)
|
1995-12-20 |
2001-02-27 |
Aventis Pharmaceuticals Inc. |
Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic disease
|
US6201124B1
(en)
|
1995-12-21 |
2001-03-13 |
Albany Molecular Research, Inc. |
Process for production of piperidine derivatives
|
US6153754A
(en)
*
|
1995-12-21 |
2000-11-28 |
Albany Molecular Research, Inc. |
Process for production of piperidine derivatives
|
US5922737A
(en)
*
|
1996-02-21 |
1999-07-13 |
Hoechst Marion Roussel, Inc. |
Substituted N-methyl-N-(4-(4-(1H-Benzimidazol-2-YL-amino) piperidin-1-YL)-2-(arlyl) butyl) benzamides useful for the treatment of allergic diseases
|
US5932571A
(en)
*
|
1996-02-21 |
1999-08-03 |
Hoechst Marion Roussel, Inc. |
Substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl) {1,4}diazepan-1-yl)-2-(aryl) butyl) benzamides useful for the treatment of allergic diseases
|
US5998439A
(en)
*
|
1996-02-21 |
1999-12-07 |
Hoescht Marion Roussel, Inc. |
Substituted N-methyl-N-(4-(piperidin-1-yl)-2-(aryl)butyl)benzamides useful for the treatment of allergic diseases
|
US5925761A
(en)
*
|
1997-02-04 |
1999-07-20 |
Sepracor Inc. |
Synthesis of terfenadine and derivatives
|
ATE260983T1
(de)
*
|
1997-03-11 |
2004-03-15 |
Aventis Pharma Inc |
Verfahren zur herstellung von 4-(4-(4- (hydroxydiphenyl)-1-piperidinyl)-1-hydroxybutyl - alpha,alpha-dimenthylphenylessigsäure und phosphorylierter derivate
|
US6451815B1
(en)
|
1997-08-14 |
2002-09-17 |
Aventis Pharmaceuticals Inc. |
Method of enhancing bioavailability of fexofenadine and its derivatives
|
DK0998272T3
(da)
*
|
1997-08-26 |
2003-08-25 |
Aventis Pharma Inc |
Farmaceutisk præparat til kombinationen piperidinoalkanoldekongestivum
|
DK0924196T3
(da)
*
|
1997-12-17 |
2003-09-29 |
Aventis Pharma Gmbh |
Fremgangsmåde til alkylering af alkyl- eller benzylcyanderivater i nærværelse af trialkylaminer eller -phosphiner
|
CA2315721C
(fr)
*
|
1997-12-23 |
2008-08-12 |
Schering Corporation |
Composition pour le traitement de maladies respiratoires et cutanees, comprenant au moins un antagoniste de leucotriene et au moins un antihistamine
|
US6194431B1
(en)
|
1998-04-14 |
2001-02-27 |
Paul D. Rubin |
Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors
|
US6683094B2
(en)
|
1998-07-02 |
2004-01-27 |
Aventis Pharmaceuticals Inc. |
Antihistaminic piperidine derivatives and intermediates for the preparation thereof
|
US6673933B2
(en)
|
1998-07-02 |
2004-01-06 |
Aventis Pharmaceutical Inc. |
Antihistaminic piperidine derivatives and intermediates for the preparation thereof
|
AU2007200674C1
(en)
*
|
1998-07-02 |
2011-02-24 |
Aventisub Llc |
Novel antihistaminic piperidine derivatives and intermediates for the preparation thereof
|
KR100707904B1
(ko)
*
|
1998-07-02 |
2007-04-16 |
아벤티스 파마슈티칼스 인크 |
항히스타민 피페리딘 유도체 및 이를 제조하기 위한 중간체
|
GB9822170D0
(en)
*
|
1998-10-13 |
1998-12-02 |
Danbioyst Uk Ltd |
Novel formulations of fexofenadine
|
IN191492B
(fr)
*
|
1999-05-25 |
2003-12-06 |
Ranbaxy Lab Ltd |
|
US6613906B1
(en)
*
|
2000-06-06 |
2003-09-02 |
Geneva Pharmaceuticals, Inc. |
Crystal modification
|
US6613907B2
(en)
|
2000-11-08 |
2003-09-02 |
Amr Technology, Inc. |
Process for the production of piperidine derivatives with microorganisms
|
CH695216A5
(de)
*
|
2001-02-23 |
2006-01-31 |
Cilag Ag |
Verfahren zur Herstellung eines nicht hydratisierten Salzes eines Piperidinderivats und eine so erhältliche neue kristalline Form eines solchen Salzes.
|
HUP0400299A2
(en)
*
|
2001-04-09 |
2007-08-28 |
Teva Pharma |
Polymorphs of fexofenadine hydrochloride
|
US20030021849A1
(en)
*
|
2001-04-09 |
2003-01-30 |
Ben-Zion Dolitzky |
Polymorphs of fexofenadine hydrochloride
|
EE200400010A
(et)
*
|
2001-06-18 |
2004-02-16 |
Dr. Reddy's Laboratories Ltd. |
4-[4-[4-(hüdroksüdifenüülmetüül)-1-piperidinüül]-1-hüdroksübutüül]-a,a-dimetüülben seenäädikhappe ja selle hüdrokloriidi uued kristalsed vormid
|
US7700779B2
(en)
*
|
2001-06-18 |
2010-04-20 |
Dr. Reddy's Laboratories Limited |
Crystalline forms of fexofenadine and its hydrochloride
|
US20030158227A1
(en)
*
|
2001-11-08 |
2003-08-21 |
Barnaba Krochmal |
Polymorphs of fexofenadine base
|
WO2003039482A2
(fr)
*
|
2001-11-08 |
2003-05-15 |
Teva Pharmaceutical Industries Ltd. |
Polymorphes a base fexofenadine
|
US6723348B2
(en)
*
|
2001-11-16 |
2004-04-20 |
Ethypharm |
Orodispersible tablets containing fexofenadine
|
EP2266590A3
(fr)
|
2002-02-22 |
2011-04-20 |
Shire LLC |
Système d'administration de substances actives et méthodes de protection et d'administration de substances actives
|
JP2005532356A
(ja)
*
|
2002-06-10 |
2005-10-27 |
テバ ファーマシューティカル インダストリーズ リミティド |
塩酸フェキソフェナジンの多型体xvi
|
BR0317364A
(pt)
*
|
2002-12-16 |
2005-11-16 |
Ranbaxy Lab Ltd |
Processo para a preparação de fexofenadina
|
WO2004067511A1
(fr)
*
|
2003-01-31 |
2004-08-12 |
Ranbaxy Laboratories Limited |
Procede de preparation de fexofenadine
|
US20050065183A1
(en)
*
|
2003-07-31 |
2005-03-24 |
Indranil Nandi |
Fexofenadine composition and process for preparing
|
US20050026890A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an antihistamine for treatment of asthma or chronic obstructive pulmonary disease
|
GB0319935D0
(en)
*
|
2003-08-26 |
2003-09-24 |
Cipla Ltd |
Polymorphs
|
TW200517114A
(en)
|
2003-10-15 |
2005-06-01 |
Combinatorx Inc |
Methods and reagents for the treatment of immunoinflammatory disorders
|
US20050256163A1
(en)
*
|
2004-04-26 |
2005-11-17 |
Ilan Kor |
Crystalline forms of fexofenadine hydrochloride and processes for their preparation
|
WO2006008567A1
(fr)
*
|
2004-06-18 |
2006-01-26 |
Wockhardt Limited |
Compositions pharmaceutiques a base de composes piperidinoalcanols
|
ITMI20041568A1
(it)
*
|
2004-07-30 |
2004-10-30 |
Dipharma Spa |
"polimorfi di fexofenadina base"
|
US7498443B2
(en)
*
|
2004-09-17 |
2009-03-03 |
Albany Molecular Research, Inc. |
Process for production of carebastine
|
US7498345B2
(en)
*
|
2004-09-17 |
2009-03-03 |
Albany Molecular Research, Inc. |
Process for production of piperidine derivatives
|
JP2008514641A
(ja)
*
|
2004-09-28 |
2008-05-08 |
テバ ファーマシューティカル インダストリーズ リミティド |
結晶形フェキソフェナジン、およびその調製方法
|
DK2486942T3
(en)
|
2004-11-24 |
2019-01-28 |
Meda Pharmaceuticals Inc |
COMPOSITIONS CONTAINING AZELASTINE AND PROCEDURES FOR USING IT
|
US8758816B2
(en)
*
|
2004-11-24 |
2014-06-24 |
Meda Pharmaceuticals Inc. |
Compositions comprising azelastine and methods of use thereof
|
US20070020330A1
(en)
*
|
2004-11-24 |
2007-01-25 |
Medpointe Healthcare Inc. |
Compositions comprising azelastine and methods of use thereof
|
JP2008120684A
(ja)
*
|
2005-03-07 |
2008-05-29 |
Kumamoto Univ |
抗アレルギー薬
|
WO2007017905A1
(fr)
*
|
2005-08-05 |
2007-02-15 |
Lupin Limited |
Compositions pharmaceutiques de fexofenadine sous forme de suspension et destinees a une administration par voie orale
|
US20070088065A1
(en)
*
|
2005-10-14 |
2007-04-19 |
Jie Du |
Metaxalone products, method of manufacture, and method of use
|
US20080292584A1
(en)
*
|
2005-10-14 |
2008-11-27 |
Mutual Pharmaceutical Company, Inc. |
Metaxalone products, method of manufacture, and method of use
|
WO2007049303A2
(fr)
*
|
2005-10-28 |
2007-05-03 |
Ind-Swift Laboratories Limited |
Procede ameliore pour preparer de la fexofenadine a purete elevee
|
CN101355876B
(zh)
|
2005-11-09 |
2012-09-05 |
康宾纳特克斯公司 |
一种适用于眼部给药的组合物
|
DOP2006000274A
(es)
*
|
2005-12-14 |
2007-10-15 |
Sanofi Aventis Us Llc |
Formulación de suspensión de fexofenadina
|
CN100443470C
(zh)
*
|
2006-07-21 |
2008-12-17 |
杭州保灵有限公司 |
一种依巴斯汀的制备方法
|
ITMI20061491A1
(it)
*
|
2006-07-27 |
2008-01-28 |
Archimica Srl |
Processo per la preparazione di fexofenadina.
|
ITMI20061492A1
(it)
*
|
2006-07-27 |
2008-01-28 |
Archimica Srl |
Processo per la preparazione di fexofenadina.
|
WO2008033466A2
(fr)
*
|
2006-09-14 |
2008-03-20 |
Combinatorx (Singapore) Pre. Ltd. |
Compositions et procédés pour le traitement de maladies virales
|
CN101940571A
(zh)
|
2007-04-13 |
2011-01-12 |
南方研究所 |
抗血管生成剂和使用方法
|
ITMI20070987A1
(it)
*
|
2007-05-16 |
2008-11-17 |
Dipharma Francis Srl |
Procedimento per la preparazione di composti chetonici
|
US20090076080A1
(en)
*
|
2007-09-19 |
2009-03-19 |
Protia, Llc |
Deuterium-enriched fexofenadine
|
US20090306135A1
(en)
|
2008-03-24 |
2009-12-10 |
Mukesh Kumar Sharma |
Stable amorphous fexofenadine hydrochloride
|
EP2288355A1
(fr)
*
|
2008-05-30 |
2011-03-02 |
Fairfield Clinical Trials LLC |
Procédé et composition pour une inflammation et une décoloration de la peau
|
US20100092479A1
(en)
*
|
2008-08-18 |
2010-04-15 |
Combinatorx (Singapore) Pte. Ltd. |
Compositions and methods for treatment of viral diseases
|
CN101585805B
(zh)
*
|
2009-06-06 |
2011-07-06 |
浙江大学宁波理工学院 |
一种抗过敏药物非索非那定盐酸盐的制备方法
|
EP2289867A3
(fr)
|
2009-08-19 |
2012-04-25 |
Jubilant Organosys Limited |
Procédé de production d'acide acétique 4-(4-halo-1-oxybutyl)-alpha, alpha-dimethylbenzene ou esthers d'alkyle associés
|
CN101671292B
(zh)
*
|
2009-10-10 |
2011-09-07 |
浙江大学宁波理工学院 |
盐酸非索非那定的合成方法
|
US20110130711A1
(en)
*
|
2009-11-19 |
2011-06-02 |
Follica, Inc. |
Hair growth treatment
|
EP2371817A1
(fr)
*
|
2010-04-01 |
2011-10-05 |
Arevipharma GmbH |
Procédé pour la préparation de 1-[4-(1,1-diméthyléthyl)phényl]-4-[4-(diphénylméthoxy)-1-pipéridinyl]-1-butanone et de sels d'addition acides correspondant
|
WO2011158262A1
(fr)
|
2010-06-15 |
2011-12-22 |
Chemelectiva S.R.L. |
Forme polymorphe du chlorhydrate de fexofénadine, intermédiaires et procédé de préparation
|
SG194625A1
(en)
|
2011-05-23 |
2013-12-30 |
Sanofi Sa |
Process for the preparation of deuterated compounds containing n-alkyl groups
|
WO2013047725A1
(fr)
|
2011-09-29 |
2013-04-04 |
塩野義製薬株式会社 |
Produit pharmaceutique thérapeutique contre la rhinite allergique comportant un antagoniste de pgd2 et un antagoniste d'histamine
|
EP2578570A1
(fr)
|
2011-10-07 |
2013-04-10 |
Almirall, S.A. |
Nouveau procédé de fabrication de 5-(2-{[6-(2,2-difluoro-2-phényléthoxy)hexyl]amino}-1-hydroxyéthyl)-8-hydroxyquinolin-2(1h)-one via de nouveaux intermédiaires de synthèse
|
EP2641900A1
(fr)
|
2012-03-20 |
2013-09-25 |
Almirall, S.A. |
Nouvelles formes polymorphes de héminapadisylate de 5-(2-{[6-(2,2-difluoro-2-phényléthoxy) hexyl]amino}-1-(R)-hydroxyéthyl)-8-hydroxyquinolin-2(1h)-one en tant qu'agoniste du récepteur adrénergique ß2
|
CN102659667B
(zh)
*
|
2012-04-20 |
2013-08-14 |
浙江启明药业有限公司 |
一种非索非那定关键中间体的合成方法
|
CN103333100B
(zh)
*
|
2013-06-06 |
2016-04-06 |
池州东升药业有限公司 |
一种盐酸非索非那定的合成工艺
|
ITMI20131652A1
(it)
|
2013-10-07 |
2015-04-08 |
Dipharma Francis Srl |
Procedimento per la purificazione di derivati dell'acido 2-fenil-2-metil-propanoico
|
CN104557671B
(zh)
*
|
2013-10-10 |
2018-04-13 |
池州东升药业有限公司 |
一种非索非那定及中间体的合成方法
|
EP2949321A1
(fr)
|
2014-05-26 |
2015-12-02 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
Formulations multicouche de fexofénadine et de montélukast
|
RS58961B1
(sr)
|
2015-01-22 |
2019-08-30 |
Sanofi Aventis Deutschland |
Proces proizvodnje 2-[4-(ciklopropankarbonil)fenil]-2-metil-propannitrila
|
DK3365327T3
(da)
|
2015-10-22 |
2020-02-24 |
Sanofi Aventis Deutschland |
Fremgangsmåde til fremstilling af fexofenadin og mellemprodukter, der anvendes deri
|
GB202212656D0
(en)
|
2022-08-31 |
2022-10-12 |
Novumgen Ltd |
An orodispersible tablet of fecofenadine and it process of preparation
|